AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed) | PAR 21 141

Opportunity Information: Apply for PAR 21 141

The National Institutes of Health (NIH) is offering a discretionary grant opportunity titled "AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed)" under funding opportunity number PAR-21-141 (CFDA 93.866). The focus is Alzheimer s disease (AD) and Alzheimer s disease-related dementias (ADRD), with the central goal of strengthening the clinical trials workforce. NIH is explicitly looking to expand both the size and diversity of the pipeline of trained AD/ADRD clinical trialists, recognizing that the field needs more people who can design, run, and improve modern dementia-focused trials.

This program supports the development of creative, innovative short-course training programs that teach state-of-the-art clinical research and clinical trial skills specifically relevant to AD/ADRD. The intent is workforce development rather than funding a trial itself, and the mechanism is an R25 education-type grant where independent clinical trials are not allowed. In practice, that means applicants should propose training and educational experiences (for example, short courses, workshops, bootcamps, or intensive modules) that prepare participants to become effective AD/ADRD trial researchers, without proposing to lead a standalone clinical trial as the core activity of the award.

A wide range of U.S.-based organizations may apply. Eligible applicants include various levels of government (state, county, city or township, and special districts), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized Native American tribal governments, and other Native American tribal organizations. The opportunity is also open to public housing authorities and Indian housing authorities, nonprofits with or without 501(c)(3) status (as long as they are not higher-education institutions in those categories), for-profit organizations other than small businesses, small businesses, and other eligible entities. NIH also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, the FOA makes clear that foreign participation is restricted: non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed.

Key administrative details included in the source information are that NIH is the issuing agency, the funding instrument is a grant, and the activity category is health. The opportunity record shows an award ceiling of $400,000. The original closing date listed is 2023-09-07, and the FOA record was created on 2021-03-04. Overall, the grant is aimed at helping organizations build well-designed, high-impact short courses that can rapidly upskill clinicians and researchers and broaden participation in the AD/ADRD clinical trials ecosystem, ultimately improving the capacity to conduct rigorous, current, and inclusive dementia clinical research.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
• This funding opportunity was created on 2021-03-04.
• Applicants must submit their applications by 2023-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $400,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 21 141

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: